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Earlier this year, the ISSCR’s incoming
president, George Daley (Figure 1),
took time out of his packed schedule
to talk about his plans for the society
for the coming year and his views on
the current status of stem cell re-
search. Daley’s offices and laboratory
are on the seventh floor of the Karp
Family Research Building, a spectacu-
lar modern addition to Children’s Hos-
pital in Boston. He is an associate pro-
fessor of biological chemistry and
molecular pharmacology at Harvard
Medical School and an associate pro-
fessor of pediatrics who sees young
patients with a variety of blood dis-
eases on a regular basis. In addition,
he serves as the Associate Director
of the Stem Cell Research Program
at Children’s, which is in its third
year, and is a founding member of
the executive committee of the Har-
vard Stem Cell Institute.
On that blustery April day, stem cells
were in the news—yet again. That very
week the U.S. Senate was due to vote
on the Stem Cell Research Enhance-
ment Act of 2007, which, if adopted,
would permit federal funds to support
work on all embryonic stem cell lines
in existence, not just those made prior
to August 9, 2001. As this article went
to press, the bill had passed the Senate
by a 63 to 34 vote but seemed likely to
fall to a presidential veto. And only the
week before, much to the elation
of researchers around the world,
the U.S. Patent and Trademark
Office had posted its preliminary
intent to revoke three patents
that involve the University of
Wisconsin and its claim of own-
ership of ES cells.
Daley has thought for some
time that two things have kept
stem cell science in a straight-
jacket during recent years, espe-
cially in the U.S.: limitations on
the funding for ES cell lines and
intellectual property rights. In re-
lation to the first, Daley, a scien-
tist who envisions ES cells lead-
ing to a revolution in the way
we study and treat disease, has
worked tirelessly to reverse the Bush
administration’s restrictions. On the
subject of patents, ‘‘It’s odd and frus-
trating,’’ he noted, ‘‘that such a funda-
mental cell type should be owned by
a corporate entity.’’
His stance on both issues corre-
sponds with the ISSCR’s respective
endorsement of the Senate bill and its
policy ‘‘of encouraging an unfettered
exchange of research materials,’’ he
pointed out. As president of the ISSCR,
he will pursue political advocacy only
when it dovetails with the society’s pri-
mary mission of supporting and pro-
moting stem cell research. The ISSCR
is ‘‘first and foremost a scientific orga-
nization,’’ he emphasized. ‘‘If there
are political efforts that oppose its
mission, we will take the opportunity
to educate the public and legislators
in locales internationally. But we are
fiercely protective of our mission and
do not want to be diverted by exces-
sive attention to political issues.’’
Daley, who chaired the task force for
the ISSCR’s Guidelines for the Con-
duct of Human Embryonic Stem Cell
Research, hopes they will become
the ‘‘international gold standard,’’ and
he plans to vigorously promote and so-
lidify those guidelines. The ISSCR’s
guidelines are unique and different
from those of other organizations, he
maintained, ‘‘in that they were issued
from the organization that has come
together to represent stem cell scien-
tists worldwide. I think that’s very,
very important. The guidelines cross
national boundaries.’’ It’s an oppor-
tune time, as he sees it, for the ISSCR
and its guiding principles to assume
a global leadership role. With stem
cell science at a relatively early stage,
‘‘I think many countries are still debat-
ing and trying to configure the kind of
regulations they’re going to put in
place,’’ he noted. ‘‘We want to try to
stay ahead of the curve, to acknowl-
edge the social context of our work,
and to take leadership in self-evalua-
tion, self-regulation, and transparency
in the conduct of stem cell science.’’
The vexing ethical questions that
surround stem cells, notes Daley, too
often steal the show, when his vision
for the ISSCR is largely dedicated to
the science—to how to build and for-
tify stem cell biology and how to put
it on track toward a time when cell
therapies will find their place within
the medical armamentarium. Will em-
bryonic or adult stem cells lead the
way? Daley stresses that research
into both are imperative for a more in-
formed future. Indeed, both versions
of stem cells make the possibilities
for treatment all the more tantalizing.
As ISSCR president, Daley will con-
tinue his predecessors’ push to get the
ISSCR on a firm financial footing,
particularly, he said, ‘‘so that
we can launch new projects.’’
One initiative, as set forth in the
guidelines, is to establish a data-
base of the world’s burgeoning
number of ES cell lines and a
warehouse for storing them. A
common bank and database,
Daley feels, would go a long
way toward establishing interna-
tional research standards and
encouraging the free exchange
of materials. The ISSCR already
is working with the International
Stem Cell Forum to promote a
set of standards for characteriz-
ing, banking, and distributing
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ISSCR’s funds has been derived from
membership fees, revenues from the
annual meeting, and corporate sup-
porters. The incoming president is ea-
ger to explore private philanthropy as
yet another way of building the organi-
zation’s revenue base. For advice and
support, the society will be putting into
place an international advisory council
of prominent players who will help ‘‘to
navigate the many political and cultural
issues that impact stem cell research,’’
he said.22 Cell Stem Cell 1, July 2007 ª2007 ElsInaddition,Daleywants to reexamine
the society’s annual meeting, which
has developed into the world’s largest
stem cell conclave. ‘‘I want to make
sure that it doesn’t become too big
and impersonal,’’ he said. ‘‘Regional
meetings could extend our reach, and
we’ll be looking at that idea as well.’’
Last, but not least, another aim for his
presidency will be to strengthen the
ISSCR’s partnership with this publica-
tion, the latest addition to the Cell Press
family of journals. As he outlined, ‘‘We
expect this new journal will serve theevier Inc.needs of our membership by giving us
a forum for presenting new programs,
policy initiatives, and other vital infor-
mation for our members.’’
Daley’s optimism about the future of
stem cell research is infectious. ‘‘The
field is tremendously exciting right
now,’’ he said. ‘‘We’re privileged as
scientists to be part of this revolution in
biology and medicine, and it’s ISSCR’s
mission to foster the highest standards
of scientific exchange to keep the field
strong and growing, so that it can ulti-
mately deliver on its promise.’’
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